Mab-9

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

PD-1 AND LAG-3 BINDING MOLECULES AND METHODS OF USE THEREOF
EP 3456346 B1Applicant: MACROGENICS INCPriority: 2015
CN
EP
US
WO
15 publications
Anti-CD19 antibodies and methods of use and preparation thereof
CN 119143877 AApplicant: CHENGDU BAILIDUOTE BIOLOGICAL PHARMACEUTICAL CO LTDPriority: 2020
CN
3 publications
Specific antibody fragments for the human carcinoembryonic antigen (cea)
US 2005158322 A1Applicant: GAILONDO COWLEY JORGE VPriority: 2002
US
2 publications
Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and beta1 integrins
- US 7566449 B2
  Applicant: UNIV SOUTHERN CALIFORNIAPriority: 2005
  US
  2 publications
- US 7101975 B1
  Applicant: UNIV SOUTHERN CALIFORNIAPriority: 2000
  US
Anti-rat angiotensin I-converting enzyme (ACE, CD143) monoclonal antibodies and uses thereof
US 2005287066 A1Applicant: MONOACE INCPriority: 2005
US
Monoclone mab-bomDpl-9 of antibody anti-cattle maturity Doppel and uses thereof
CN 101402684 AApplicant: LANZHOU INST OF VETERINARY SCIPriority: 2008
CN
Immunoassay for detecting tumor pyruvate kinase M2
US 11255856 B2Applicant: RAZZAQI MAHBOUBEHPriority: 2020
US
Mouse model of myocarditits
US 11602134 B2Applicant: PEKING UNION MEDICAL COLLEGE HOSPITALPriority: 2021
US
一种纤溶酶-α2抗纤溶酶复合物单克隆抗体及其制备和应用
CN 116284415 BApplicant: 山东大学Priority: 2022
CN
Anti-SDcatcher and GVopti murine monoclonal antibody as well as preparation method and application thereof
CN 117106079 AApplicant: ZHANG HUIPriority: 2023
CN

Drugs

Mab-9

Patents

Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and beta1 integrins